Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 229

1.

Bile duct apoptosis and cholestasis resembling acute graft-versus-host disease after autologous hematopoietic cell transplantation.

Saunders MD, Shulman HM, Murakami CS, Chauncey TR, Bensinger WI, McDonald GB.

Am J Surg Pathol. 2000 Jul;24(7):1004-8.

PMID:
10895823
[PubMed - indexed for MEDLINE]
2.

Lymphocytic gastritis resembling graft-vs.-host disease following autologous hematopoietic cell transplantation.

Tzung SP, Hackman RC, Hockenbery DM, Bensinger W, Schiffman K, McDonald GB.

Biol Blood Marrow Transplant. 1998;4(1):43-8.

PMID:
9701391
[PubMed - indexed for MEDLINE]
3.

Crypt loss is a marker of clinical severity of acute gastrointestinal graft-versus-host disease.

Melson J, Jakate S, Fung H, Arai S, Keshavarzian A.

Am J Hematol. 2007 Oct;82(10):881-6.

PMID:
17570511
[PubMed - indexed for MEDLINE]
5.

Hepatitic graft-versus-host disease after hematopoietic stem cell transplantation: clinicopathologic features and prognostic implication.

Ma SY, Au WY, Ng IO, Lie AK, Leung AY, Liang R, Lau GK, Kwong YL.

Transplantation. 2004 Apr 27;77(8):1252-9.

PMID:
15114094
[PubMed - indexed for MEDLINE]
6.

Chronic graft-versus-host disease of the liver: presentation as an acute hepatitis.

Strasser SI, Shulman HM, Flowers ME, Reddy R, Margolis DA, Prumbaum M, Seropian SE, McDonald GB.

Hepatology. 2000 Dec;32(6):1265-71.

PMID:
11093733
[PubMed - indexed for MEDLINE]
7.

Hepatic graft-versus-host disease presenting as an acute hepatitis after allogeneic peripheral blood stem cell transplantation.

Fujii N, Takenaka K, Shinagawa K, Ikeda K, Maeda Y, Sunami K, Hiramatsu Y, Matsuo K, Ishimaru F, Niiya K, Yoshino T, Hirabayashi N, Harada M.

Bone Marrow Transplant. 2001 May;27(9):1007-10.

PMID:
11436113
[PubMed - indexed for MEDLINE]
Free Article
8.

Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.

Talmadge JE.

Int Immunopharmacol. 2003 Aug;3(8):1121-43. Review.

PMID:
12860168
[PubMed - indexed for MEDLINE]
9.

Gastrointestinal pathology of autologous graft-versus-host disease following hematopoietic stem cell transplantation: a clinicopathological study of 17 cases.

Cogbill CH, Drobyski WR, Komorowski RA.

Mod Pathol. 2011 Jan;24(1):117-25. doi: 10.1038/modpathol.2010.163. Epub 2010 Oct 15.

PMID:
20953169
[PubMed - indexed for MEDLINE]
Free Article
10.

[Analysis of acute liver "graft-versus-host disease" following allogeneic myeloablative stem cell transplant].

Doki N, Saito Y, Hatsumi N, Irisawa H, Sakura T, Miyawaki S.

Rinsho Ketsueki. 2004 Jan;45(1):57-60. Japanese.

PMID:
14999935
[PubMed - indexed for MEDLINE]
11.

Macrophage migratory inhibitory factor (MIF) expression in acute graft-versus-host disease (GVHD) in allogeneic hemopoietic stem cell transplant recipients.

Lo JW, Leung AY, Huang XR, Lie AK, Metz C, Bucala R, Liang R, Lan HY.

Bone Marrow Transplant. 2002 Sep;30(6):375-80.

PMID:
12235522
[PubMed - indexed for MEDLINE]
Free Article
12.

Allogeneic cell therapy for patients who relapse after autologous stem cell transplantation.

Porter DL, Luger SM, Duffy KM, Stadtmauer EA, Laport G, Schuster SJ, Orloff G, Tsai D, McDaid K, Kathakali A, Leonard DG, Antin JH.

Biol Blood Marrow Transplant. 2001;7(4):230-8.

PMID:
11349810
[PubMed - indexed for MEDLINE]
13.

Serum cytokeratin-18 fragments as quantitative markers of epithelial apoptosis in liver and intestinal graft-versus-host disease.

Luft T, Conzelmann M, Benner A, Rieger M, Hess M, Strohhaecker U, Görner M, Hegenbart U, Ho AD, Dreger P.

Blood. 2007 Dec 15;110(13):4535-42. Epub 2007 Aug 16.

PMID:
17702900
[PubMed - indexed for MEDLINE]
Free Article
14.
15.

Gastrointestinal graft-versus-host disease in recipients of autologous hematopoietic stem cells: incidence, risk factors, and outcome.

Holmberg L, Kikuchi K, Gooley TA, Adams KM, Hockenbery DM, Flowers ME, Schoch HG, Bensinger W, McDonald GB.

Biol Blood Marrow Transplant. 2006 Feb;12(2):226-34.

PMID:
16443520
[PubMed - indexed for MEDLINE]
16.

Enhancement of cyclosporin A-induced autologous graft-versus-host disease after peripheral blood stem cell transplantation by utilizing selected CD34(+) cells.

Miura Y, Ueda M, Takami A, Shiobara S, Nakao S, Hess AD.

Bone Marrow Transplant. 2003 Oct;32(8):785-90.

PMID:
14520422
[PubMed - indexed for MEDLINE]
17.

Systemic aspergillosis in a patient with non-Hodgkin's lymphoma developing acute graft-versus-host disease after autologous peripheral blood stem cell transplantation.

Messina G, Quartarone E, Console G, Cuzzola M, Iacopino O, Martino M, Irrera G, Morabito F, Iacopino P.

Haematologica. 2002 Jul;87(7):ECR22.

PMID:
12091138
[PubMed - indexed for MEDLINE]
18.

Enlargement of the common bile duct in patients with acute graft-versus-host disease: what does it mean?

Ketelsen D, Vogel W, Bethge W, Werner M, Dietz K, Claussen CD, Horger M.

AJR Am J Roentgenol. 2009 Sep;193(3):W181-5. doi: 10.2214/AJR.08.1953.

PMID:
19696256
[PubMed - indexed for MEDLINE]
19.

Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients.

Shaiegan M, Iravani M, Babaee GR, Ghavamzadeh A.

Transpl Immunol. 2006 Jan;15(3):223-7. Epub 2005 Nov 28.

PMID:
16431290
[PubMed - indexed for MEDLINE]
20.

Eczematoid graft-vs-host disease: a novel form of chronic cutaneous graft-vs-host disease and its response to psoralen UV-A therapy.

Creamer D, Martyn-Simmons CL, Osborne G, Kenyon M, Salisbury JR, Devereux S, Pagliuca A, Ho AY, Mufti GJ, du Vivier AW.

Arch Dermatol. 2007 Sep;143(9):1157-62.

PMID:
17875877
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk